Related Experiment Videos
[Long term therapy with nitrazepam in children with infantile spasms and myoclonic-astatic fits]
Insights
RADEDORM effectively treated infantile convulsions and myoclonic-static fits in children. While results varied, a significant portion experienced reduced or eliminated seizures with minimal side effects.
Area of Science:
- Pediatric Neurology
- Clinical Pharmacology
Context:
- Infantile convulsion and myoclonic-static epilepsy are significant neurological challenges in children.
- Previous treatment options had limitations in efficacy and side effect profiles.
Purpose:
- To evaluate the efficacy and safety of RADEDORM in treating infantile convulsion and myoclonic-static fits.
- To assess the impact of RADEDORM on seizure frequency, developmental status, and neurological findings.
Summary:
- RADEDORM was administered to 54 children with infantile convulsion and myoclonic-static fits.
- Therapeutic outcomes included 35% seizure-free, 20% with 75-99% reduction, and 6% with 50-74% reduction.
- Treatment effectiveness was generally good, though less pronounced in myoclonic-astatic fits and cases with grand mal epilepsy. Age influenced outcomes, with younger children responding less favorably than older children.
Impact:
- RADEDORM demonstrated a good therapeutic effect in managing pediatric epilepsy syndromes.
- The drug exhibited a favorable side effect profile, rarely necessitating dosage reduction.
- Electroencephalogram findings generally correlated with treatment outcomes, supporting its clinical utility.
Abstract:
Since 1968 54 children with infantile convulsion and myoclonic-static fits have been treated with RADEDORM (minimum dosage 2x1/2 tablets, maximum 1--1,5 mg/kg body weight) in the Neuropediatric department of the University Pediatric Clinic in Leipzig. Most of the patients showed a retarded statical and mental development, 50% pathological neurological results. The results of the therapy (35% free of attacks; in 20% a reduction in frequency of attacks of 75--99%; in 6% of 50--74%, in 39% less than 50%, respectively no effect) can be said to be good. Myoclonic-astatic fits were semowhat less favourably influenced than infantile-convulsions. A combination with grand mal epilepsy also had a negative effect on such cases. The results of the treatment were independent of intelligence and duration of illness, however they were not so good in infants as in young children. The electroencephalogram showed with little exception a considerable conformity with the results of the treatment. The side-effects were relatively small and only seldom demanded a reduction in dosage.